Birdwatch Archive

Birdwatch Note Rating

2024-10-23 15:23:57 UTC - NOT_HELPFUL

Rated by Participant: A4505A377DE47962492F83287D5989ED7D383309698045600E8501FEE253ECF5
Participant Details

Original Note:

Misleading headline. The drugs will not be banned, they will simply not be funded/available to NHS patients due to prohibitive cost. The drugs have been declared safe and will be available to private patients or as part of clinical trials, as per the linked article. https://www.telegraph.co.uk/news/2024/10/22/donanemab-alzheimers-effective-wonder-drug-nhs-ban/

All Note Details

Original Tweet

All Information

  • noteId - 1849046046686449749
  • participantId -
  • raterParticipantId - A4505A377DE47962492F83287D5989ED7D383309698045600E8501FEE253ECF5
  • createdAtMillis - 1729697037197
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 1849046046686449749A4505A377DE47962492F83287D5989ED7D383309698045600E8501FEE253ECF5